News & Events about Precigen Inc.
Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock Precigen Announces Pricing of $75.0 Million Public Offering of Common Stock PR Newswire GERMANTOWN, Md., Jan. 24, 2023 GERMANTOWN, Md., Jan. 24, 2023 /PRNewswire/ -- Precigen, Inc.(Nasdaq: PGEN) today announced the pricing...
Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T...
Ticker Report
2 months ago
Cantor Fitzgerald started coverage on shares of Precigen (NASDAQ:PGEN Get Rating) in a research note issued to investors on Friday, The Fly reports. The firm issued an overweight rating and a $7.00 price objective on the biotechnology companys stock. A number of other equities ...
Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics PR Newswire GERMANTOWN, Md., Aug. 22, 2022 Proceeds include $170 million in upfront cash and up to $10 million earn-out over two years GERMANTOWN, Md...